Lan Li

Lan Li is an accomplished leader in bioanalysis with extensive experience in the pharmaceutical industry, currently serving as VP and Global Head of Bioanalysis at WuXi AppTec since May 2018. Prior to this role, Lan Li contributed significantly to Alexion Pharmaceuticals, Inc. in various leadership positions, including Director of Research Strategy and Portfolio Management, where responsibilities included managing research pipeline strategic planning, external collaborations, and scientific communication. As Director of Bioanalytical Sciences, key contributions included achieving global marketing approvals for Soliris and Strensiq, as well as developing bioanalytical strategies for assessing biological therapeutics. Additionally, Lan Li has a strong foundation in bioanalytical sciences, having built laboratories compliant with regulatory standards and played a crucial role in the development of therapeutic candidates like eculizumab. Lan Li holds a degree from the University of Nebraska Medical Center.